Ilona Seferyńska

Status of minimal residual disease after induction predicts outcome in both standard and high‐risk Ph‐negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4‐2002 MRD Study

Jerzy Hołowiecki, Małgorzata Krawczyk‐Kuliś, Sebastian Giebel et al. · British Journal of Haematology · 2008 · 143 citations · Full text

Medicine, Hematology, Oncology +17

Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells

Elisabeth Bolton-Gillespie, Mirle Schemionek, Hans‐Ulrich Klein et al. · Blood · 2013 · 132 citations · Full text

Medicine, Genetics, Molecular Genetics +12

Comparison of Cladribine Plus Cyclophosphamide With Fludarabine Plus Cyclophosphamide As First-Line Therapy for Chronic Lymphocytic Leukemia: A Phase III Randomized Study by the Polish Adult Leukemia Group (PALG-CLL3 Study)

Tadeusz Robak, Krzysztof Jamroziak, Joanna Góra‐Tybor et al. · Journal of Clinical Oncology · 2010 · 99 citations · Full text

Medicine, Oncology, Pharmacology +16

BCR/ABL Inhibits Mismatch Repair to Protect from Apoptosis and Induce Point Mutations

Tomasz Stokłosa, Tomasz Popławski, Mateusz Koptyra et al. · Cancer Research · 2008 · 97 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells

Margaret Nieborowska-Skorska, Katherine Sullivan, Yashodhara Dasgupta et al. · Journal of Clinical Investigation · 2017 · 76 citations · Full text

Life Sciences, Molecular Biology, Oncology +17